Limited legal protection for Covid vaccine makers hampers EU deals
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
February 03, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, FEBRUARY 03, 2023
Limited legal protection for Covid vaccine makers hampers EU deals

Coronavirus chronicle

Reuters
26 August, 2020, 03:35 pm
Last modified: 26 August, 2020, 03:38 pm

Related News

  • If Turkey blocks Sweden and Finland, will NATO boot Turkey?
  • Europeans dial down the heating, heed calls to save energy
  • EU plans changes to pharmaceuticals law to avoid medicine shortages
  • Davos 2023: EU to counter US climate game changer with own green deal
  • EU should put Twitter under direct supervision after missteps: German official

Limited legal protection for Covid vaccine makers hampers EU deals

With vaccines being developed at record speed during the pandemic, there is potentially a greater risk they may have unexpected consequences or may not be effective. The financial coverage of these liabilities is a key feature of drugmakers’ talks with governments keen to secure vaccine shots in advance

Reuters
26 August, 2020, 03:35 pm
Last modified: 26 August, 2020, 03:38 pm
A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020/Reuters
A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020/Reuters

The European Union is offering only partial protection to vaccine makers against legal risks from side-effects of their potential Covid-19 shots, European officials said, in a move that is hampering deals and contrasts with US policy.

With vaccines being developed at record speed during the pandemic, there is potentially a greater risk they may have unexpected consequences or may not be effective. The financial coverage of these liabilities is a key feature of drugmakers' talks with governments keen to secure vaccine shots in advance.

In these extraordinary circumstances, EU governments "are ready to financially cover certain of the companies' risks", an EU official told Reuters. The official added, however, that the EU's strict rules on liability remain in place.

These rules consider vaccine makers and other manufacturers liable for their products on sale in the EU, apart from rare cases when, for instance, they did not put them into circulation.

The EU's top court increased the burden on drugmakers in 2017 when it ruled vaccine users were entitled to compensation if they could prove a shot caused a negative side-effect, even when there was no scientific consensus on the matter.

Reducing the legal burden for vaccine makers has been an EU priority during the pandemic because it is considered crucial to convincing drugmakers to invest in risky vaccines, an EU internal document dated May 7 and seen by Reuters shows.

STUMBLING BLOCK

But offers made to vaccine makers have not always been in line with their expectations.

EU officials involved in the confidential negotiations told Reuters in July that liability issues were among the stumbling blocks in talks with US drugmakers Johnson & Johnson (J&J) and Pfizer, which is developing a potential Covid-19 vaccine with German biotech firm BioNtech.

The EU later said negotiations with J&J were at an advanced stage, though no deal has yet been reached.

A European Commission spokesman declined to comment on whether liability issues have been a hurdle in talks with vaccine makers.

The supply agreement the EU reached earlier in August on the potential Covid-19 vaccine developed by AstraZeneca and the University of Oxford - the only deal struck so far by Brussels - offers only partial liability coverage.

"The contract foresees that liabilities and financial costs are shared among the parties," the Belgian medicines agency said in a statement about the deal the Commission reached with AstraZeneca on behalf of all 27 EU states, including Belgium.

"Advance purchase agreements provide for member states to indemnify the manufacturer for certain liabilities incurred," a Commission official said when asked about the deal. The official gave no further details.

The industry trading body, Vaccines Europe, said it was working with relavant authorities to agree a system of compensation that would avoid "endless delays through prohibitively expensive litigation with uncertain outcomes".

Among its members are AstraZeneca, Pfizer, Sanofi, GlaxoSmithKline and CureVac CVAC.O, all of which have been involved in talks with the EU on their potential Covid-19 vaccines.

The EU stance on liabilities could partly explain why, despite having a bigger population than the United States, it is lagging Washington in securing potential Covid-19 vaccines.

The US system shifts liability for vaccines fully to the government and shields drugmakers because widespread inoculation against disease is considered a benefit to society.

Congress set aside $30 billion this year to fight Covid-19, including funding vaccine development and possibly any necessary compensation.

The EU's equivalent to that is an emergency fund that has been tapped during the pandemic and is expected to use about 2 billion euros ($2.4 billion) to help vaccine makers to develop shots and cover their liabilities, EU officials said.

Coronavirus Vaccine / Europe / Vaccine Law

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Let's be big enough to accept this economic gift
    Let's be big enough to accept this economic gift
  • Shipped Bhola gas to cost higher, yet cheaper than spot LNG
    Shipped Bhola gas to cost higher, yet cheaper than spot LNG
  • Infographic: TBS
    DNCC hospital asked to keep isolation ward ready as Nipah spreads to 28 districts

MOST VIEWED

  • Tourists ride a tour bus in Hong Kong, China October 25, 2019. REUTERS/Ammar Awad
    Hong Kong says 'hello' to woo back visitors after Covid
  • People wearing face masks following the coronavirus disease (Covid-19) outbreak are seen at Beijing Daxing International Airport in Beijing, China July 23, 2020. Photo:Reuters
    Pandemic to paradise: Chinese tourists return to Bali after three years
  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs

Related News

  • If Turkey blocks Sweden and Finland, will NATO boot Turkey?
  • Europeans dial down the heating, heed calls to save energy
  • EU plans changes to pharmaceuticals law to avoid medicine shortages
  • Davos 2023: EU to counter US climate game changer with own green deal
  • EU should put Twitter under direct supervision after missteps: German official

Features

Andy Mukherjee. Sketch: TBS

What makes India's billionaires' support special for Adani

7h | Panorama
Photo: Rejaul Hafiz Rahi

A jackal farewell

8h | Earth
The trio spearheading the revival of book cover designs

The trio spearheading the revival of book cover designs

9h | Panorama
Six Jeep Wranglers and a special XJ Jeep Cherokee set out into the depths of Lalakhal, Sylhet for an experience of a lifetime. Photo: Ahbaar Mohammad

Jeep Life Bangladesh: A club for Jeep owners to harness the power of their vehicles

1d | Wheels

More Videos from TBS

A proper price formula can help investors to plan big

A proper price formula can help investors to plan big

23h | TBS Round Table
Rumors about Sarika that everyone thinks are true

Rumors about Sarika that everyone thinks are true

21h | TBS Entertainment
Mugging rife in Tejgaon, murder in Wari

Mugging rife in Tejgaon, murder in Wari

1d | TBS Current Affairs
What secrets are hidden behind Adani's wealth?

What secrets are hidden behind Adani's wealth?

22h | TBS Stories

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Photo: Collected
Energy

8 Ctg power plants out of production

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

6
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]